Introduction
Neratinib is a targeted therapy medication used primarily in oncology. It is an irreversible tyrosine kinase inhibitor that specifically targets the HER2/neu receptor, which is involved in the growth and spread of certain types of cancer cells. It is used in the treatment of HER2-positive breast cancer.
Uses
Neratinib is indicated for:
- Breast Cancer: It is used in the adjuvant treatment of HER2-positive breast cancer following trastuzumab-based therapy. It is typically used in cases of early-stage breast cancer with a high risk of recurrence.
| Brand Name | Neratinib |
|---|---|
| Type | |
| Weight | |
| Generic | Neratinib |
| Manufacturer | |
| Available in | English বাংলা |
Mechanism of Action
Neratinib works by irreversibly binding to and inhibiting the tyrosine kinase domain of the HER2/neu receptor, as well as other related receptors (HER1, HER4). This inhibition prevents the activation of signaling pathways that promote cancer cell proliferation and survival, leading to reduced tumor growth and metastasis.
How Long Does It Take to Work?
Patients may start to see clinical benefits within a few weeks of starting neratinib. However, the full therapeutic effect may take several months, depending on the response of the cancer to the treatment and individual patient factors.
Absorption
Neratinib is absorbed from the gastrointestinal tract. It has a moderate bioavailability and is generally well-absorbed following oral administration. The presence of food can affect its absorption, with a high-fat meal potentially increasing the drug's absorption.
Route of Elimination
Neratinib is primarily eliminated via the liver. It undergoes extensive metabolism in the liver, with excretion occurring through both the urine and feces.
Dosage
The typical dosage of neratinib for the treatment of HER2-positive breast cancer is:
- Adults: 240 mg orally once daily. The duration of treatment can vary depending on patient response and tolerability.
Administration
Neratinib is administered orally in the form of tablets. It should be taken at the same time each day to maintain consistent blood levels. It is recommended to take the medication with food to reduce gastrointestinal side effects.
Side Effects
Common side effects of neratinib include:
- Diarrhea
- Nausea
- Fatigue
- Vomiting
- Anorexia
Serious side effects can include liver toxicity, rash, and electrolyte imbalances. Monitoring for these adverse effects is important during treatment.
Toxicity
Toxicity may manifest as severe diarrhea, liver enzyme elevations, or rash. Dose modifications or supportive treatments may be required to manage these adverse effects.
Precautions
Precautions include:
- Monitoring for gastrointestinal symptoms, particularly diarrhea, and managing them proactively.
- Regular liver function tests to monitor for liver toxicity.
- Use with caution in patients with pre-existing liver conditions or those on medications that affect liver function.
Interaction
Neratinib can interact with other medications, particularly those that affect liver enzymes (e.g., CYP3A4 inhibitors or inducers). It's important to inform healthcare providers of all other medications being taken to avoid potential interactions.
Disease Interaction
Patients with hepatic impairment or a history of severe gastrointestinal conditions should use neratinib with caution. Dose adjustments may be necessary based on liver function and overall health status.
Drug Interaction
Drugs that affect the CYP3A4 enzyme system can impact neratinib levels. Co-administration with strong CYP3A4 inhibitors (e.g., ketoconazole) may increase neratinib levels, while inducers (e.g., rifampin) may decrease its effectiveness.
Food Interactions
Neratinib should be taken with food to minimize gastrointestinal side effects and improve absorption. Avoiding grapefruit and grapefruit juice is recommended as they can affect drug metabolism.
Pregnancy Use
Neratinib is classified as a Category D medication for pregnancy, meaning there is evidence of risk to the fetus. It should not be used during pregnancy unless clearly needed, and effective contraception should be used during treatment.
Lactation Use
The use of neratinib during lactation is not recommended due to potential adverse effects on the infant. Women should avoid breastfeeding while on this medication.
Acute Overdose
In case of acute overdose, seek immediate medical attention. Management of overdose primarily involves supportive care and monitoring for adverse effects.
Contraindication
Neratinib is contraindicated in individuals with known hypersensitivity to the drug or its components. Caution is advised for patients with severe liver impairment.
Use Direction
Follow the prescribed dosage and administration instructions. Adhere to dietary recommendations (taking with food) and avoid medications that may interact with neratinib.
Storage Conditions
Store neratinib tablets at room temperature, away from moisture and heat. Keep out of reach of children.
Volume of Distribution
The volume of distribution for neratinib is not well-documented in standard resources but is influenced by its distribution in body tissues and organs following oral administration.
Half Life
The approximate half-life of neratinib is about 24-30 hours, allowing for once-daily dosing. This can vary based on individual patient metabolism and other factors.
Clearance
Neratinib is primarily cleared through the liver, with some excretion occurring through the urine. The clearance rate can be affected by liver function and other individual patient factors.
See in details version Neratinib also Neratinib in bangla
